Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - cabazitaxelum - solution à diluer et solvant pour solution pour perfusion - cabazitaxelum 60 mg ut cabazitaxeli acetoni solvatum, polysorbatum 80, acidum citricum monohydricum, pro vitro. solvens: ethanolum 96 per centum 573.3 mg, aqua ad iniectabile ad solutionem pro 4.5 ml. - citostatici - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

verfora sa - ibuprofenum - sospensione, bustine - ibuprofenum 150 mg, saccharum 3.75 g, sorbitolum liquidum non cristallisabile 750 mg, xanthani gummi, polysorbatum 80, acidum citricum monohydricum, dinatrii edetas, ethanolum anhydricum 25.2 mg, aromatica (orange), natrii cyclamas, e 211 18.8 mg, aqua ad suspensionem corresp. natrium 6.9 mg. - un antiflogistico, analgesico, antipiretico - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - haemagglutininum influenzae a (h1n1) (rha) (virus souche a/michigan/45/2015)-like: reassortant virus nymc x-275 derived from a/michigan/45/2015), haemagglutininum influenzae a (h3n2) (rha) (virus souche a/singapore/infimh-16-0019/2016)-like: reassortant virus ivr-186 derived form a/singapore/infimh-16-0019/2016), haemagglutininum influenzae b (rha) (virus souche b/phuket/3073/2013-like: reassortant virus b/phuket/3073/2013 (yamagata lineage)) - solution injectable dans une seringue pré-remplie - haemagglutininum influenzae a (h1n1) (adnr) (virus souche a/michigan/45/2015)-like: reassortant virus nymc x-275 derived from a/michigan/45/2015) 45 µg, haemagglutininum influenzae a (h3n2) (adnr) (virus souche a/singapore/infimh-16-0019/2016)-like: reassortant virus ivr-186 derived form a/singapore/infimh-16-0019/2016) 45 µg, haemagglutininum influenzae b (adnr) (virus souche b/phuket/3073/2013-like: reassortant virus b/phuket/3073/2013 (yamagata lineage)) 45 µg, haemagglutininum influenzae b (adnr) (virus souche b/colorado/6/2017-like: reassortant virus nymc bx-69a derived from b/maryland/15/2016 (victoria lineage)) 45 µg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas dodecahydricus, natrii chloridum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 1.84 mg, residui: octoxinolum-9. - immunisation active contre l'influenza, dès 18 ans - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

labatec pharma sa - ketaminum - solution injectable / solution à diluer pour perfusion - ketaminum 10 mg ut ketamini hydrochloridum, benzethonii chloridum, natrii chloridum corresp. natrium 2.96 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - l'anestesia di breve durata - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

labatec pharma sa - ketaminum - solution injectable / solution à diluer pour perfusion - ketaminum 50 mg ut ketamini hydrochloridum, benzethonii chloridum, natrii chloridum corresp. natrium 0.63 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - l'anestesia di breve durata - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

chiesi sa - beclometasoni dipropionas, formoteroli fumaras dihydricus, glycopyrronium - solution pour inhalation en flacon pressurisé - beclometasoni dipropionas 87.4 µg, formoteroli fumaras dihydricus 5.2 µg, glycopyrronii bromidum 10.9 µg corresp. glycopyrronium 9 µg, ethanolum anhydricum 8.856 mg, acidum hydrochloridum, norfluranum, ad aerosolum, pro dosi. - bronchopneumopathie chronique obstructive (bpco) (trimbow 87/5/9 mcg), asthme (trimbow 172/5/9 mcg) - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

chiesi sa - beclometasoni dipropionas, formoteroli fumaras dihydricus, glycopyrronium - solution pour inhalation en flacon pressurisé - beclometasoni dipropionas 172.3 µg, formoteroli fumaras dihydricus 5 µg, glycopyrronii bromidum 10.6 µg corresp. glycopyrronium 9 µg, ethanolum anhydricum 8.856 mg, acidum hydrochloridum, norfluranum, ad aerosolum, pro dosi. - bronchopneumopathie chronique obstructive (bpco) (trimbow 87/5/9 mcg), asthme (trimbow 172/5/9 mcg) - synthetika

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

aziende chimiche riunite angelini francesco acraf spa - olanzapina - olanzapina

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

labatec pharma sa - brimonidini tartras, brimonidinum - collyre en solution - brimonidini tartras 2 mg corresp. brimonidinum 1.3 mg, poly(alcohol vinylicus), natrii chloridum, natrii citras dihydricus, acidum citricum monohydricum, benzalkonii chloridum 50 µg, acidum hydrochloridum aut natrii hydroxidum ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - glaucome à grand angle, hypertension oculaire - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - milrinonum - solution injectable / pour perfusion - milrinonum 1 mg, acidum lacticum, glucosum, natrii hydroxidum aut acidum lacticum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 1.3225 mg. - insufficienza cardiaca - synthetika